- Home
- About NICHD
- Organization
- Division of Extramural Research (DER)
- Extramural Scientific Branches
- Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB)
- Branch-Specific Funding Opportunity Announcements (FOAs)
OPPTB Funding Opportunity Announcements (FOAs)
| Announcement Number | Submissions Date(s) | Expiration Date | Activity Code(s) | Title |
|---|---|---|---|---|
| PAR-17-191 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
May 8, 2020 | R03 | Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R03) |
| PAR-17-199 | Standard dates apply, by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
January 6, 2020 | R43 | Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R43) |
| PAR-17-192 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
May 8, 2020 | R21 | Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R21) |
| PAR-17-200 | Standard dates apply, by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
January 6, 2020 | R41 | Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R41) |
| PAR-17-193 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
May 8, 2020 | R01 | Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R01) |
| PAR-17-188 | August 7, 2017; November 7, 2017; April 4, 2018; August 7, 2018; November 7, 2018; April 4, 2019; August 7, 2019; November 7, 2019; April 3, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | April 4, 2020 | R03 | Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R03) |
| PAR-17-169 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | May 8, 2020 | R21 | Biomarkers: Bridging Pediatric and Adult Therapeutics (R21) |
BACK TO TOP